Study of Acute Kidney Injury in Patients Hospitalized with COVID-19: A Single Center Study in Bangladesh

Authors

  • Md Maqsudur Rasul Classified Medical Specialist and Nephrologists
  • AKM Mijanur Rahman Classified Medical Specialist and Nephrologists
  • Azizur Rahman Classified Paediatric Nephrologists
  • Tahmeed Hussain Classified Medical Specialist and Nephrologists
  • Sanjoy Kanto Nath Classified Medical Specialist and Nephrologists
  • Miskat Joha Graded Medical Specialist
  • Dewan Mohaimenul Haque Graded Medical Specialist

DOI:

https://doi.org/10.3329/jbcps.v40i2.58687

Keywords:

Acute kidney injury (AKI); Corona virus disease- 19(COVID-19); Severe disease

Abstract

Introduction: The incidence of acute kidney injury (AKI) associated with hospitalized corona virus disease -19(Covid- 19) patients and associated outcomes are not well determined. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19.

Material & Methods: In this cross sectional study, we reviewed the health records for all conveniently selected patients hospitalized with Covid-19 irrespective of co morbidity from 1st May to 31st July, 2020, at combined military hospital Dhaka, Bangladesh. Patients younger than 18 years, end stage kidney disease or with a kidney transplant recipient were excluded from the study. AKI was deûned according to kidney disease improving global outcome (KDIGO) criteria.

Results: A total of 470 Covid-19 patients were recruited in this current study, out of them 67.02% were male and 32.98% of were female; with male to female ratio was 2:1. The mean age of the study population was 54.71(±14.31) years. AKI developed among 106 (22.55%) patients of whom 50 patients had CKD. The peak stages of AKI were stage 3 in 58(12.34%), followed by stage 1 in 37(7.87%), and stage 2 in 11(2.34%) patients. Renal replacement therapy was required (RRT) for  37(7.87%) patients. Risk factors included older age, hypertension, diabetes mellitus, cardiovascular disease, and chronic kidney disease and those who presented with prolong fever and breathlessness.AKI was commonly seen in patients with severe disease. Considerable number of patient had proteinuria 222(47.23%) and haematuria in 63 (13.40%) and were significantly associated with AKI. Elevated level of ferritin, D-dimer and procalcitonin were observed among 249(52.98%), 179(38.08%) and 138(35, 88%) patients respectively which were substantially correlated with AKI. COVID-19 patients complicated to acute kidney injury were strongly associated with higher mortality19 of 23 (82.60%).

Conclusion: Renal involvement in COVID-19 (Corona virus-nephropathy) has a complex etiology. It is closely associated with severity of disease and indicating poor prognosis. Further study will be needed for better understanding the causes of AKI and patient outcomes.

J Bangladesh Coll Phys Surg 2022; 40: 79-86

Downloads

Download data is not yet available.
Abstract
41
PDF
54

Downloads

Published

2022-04-10

How to Cite

Rasul, M. M. ., Rahman, A. M. ., Rahman, A. ., Hussain, T. ., Nath, S. K. ., Joha, M. ., & Haque, D. M. . (2022). Study of Acute Kidney Injury in Patients Hospitalized with COVID-19: A Single Center Study in Bangladesh. Journal of Bangladesh College of Physicians and Surgeons, 40(2), 79–86. https://doi.org/10.3329/jbcps.v40i2.58687

Issue

Vol. 40 No. 2 (2022)

Section

Original Articles

License

Submission of a manuscript for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted manuscripts become the permanent property of the Journal of Bangladesh College of Physicians and Surgeons and may not be reproduced by any means in whole or in part without the written consent of the publisher.

No part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Reprints of any article in the Journal will be available from the publisher.